A protein-engineering strategy, in which a constitutively active form of an immune receptor is kept inactive by a peptide ...

The H5N1 avian flu is circulating in cows and other mammals. Whether it will make a permanent leap to humans is another ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...

H5N1 avian influenza has long been a concerning virus. Since its discovery in 1996 in waterfowl, bird flu has occasionally ...

Researchers from the Universities of Basel and Zurich (UZH) have sequenced the genome of the Spanish flu virus, thanks to a ...

Researchers from the universities of Basel and Zurich have used a historical specimen from UZH's Medical Collection to decode ...

DelveInsight's, “Oncolytic Virus Cancer Therapy Pipeline Insight, 2025,” report provides comprehensive insights about 120+ ...

Researchers from the universities of Basel and Zurich have used a historical specimen from UZH’s Medical Collection to decode ...

The instinct to protect and secure a child’s future—especially when it comes to their health—is one of the deepest and most ...

Pierre Fabre leads global development of tab-cel, an innovative therapy for EBV+ PTLD, with ongoing trials and potential FDA ...

In a session titled, Better meeting the needs of people living with HIV, health experts reminded us that science, care, and human rights must move together if we are to achieve real change.

VANCOUVER – Baystreet.caNews Commentary – Budget cuts are on the horizon for funding scientific research, and if supported by ...